With their participation in the completion of the largest cloud-based analysis of genome sequence data, researchers from the Baylor College of Medicine Human Genome Sequencing Center are helping to usher genomic scientists and clinicians around the world into a new era of high-level data analysis. (A “cloud” is a virtual network of remote internet servers […]
Boston/Leuven — Cartagenia, the world leader in providing genetic labs and clinicians with software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, today announced that more than 120 labs and clinics across three continents have now adopted and are relying on its Bench platform genetics diagnostics solution for use in daily […]
CAMBRIDGE, Mass.– NextCODE Health, a new private company enabling accelerated diagnosis of genetic diseases through the use of sequence data, announced today that it has secured an exclusive license for sequence-based clinical diagnostic applications using technology developed by deCODE genetics. The company also secured $15 million in Series A financing from Polaris Partners and ARCH […]
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the opening of a new Center for Innovation in Hopkinton, Massachusetts. The facility features a state-of-the-art laboratory space where PerkinElmer engineers, scientists and customers can interact and share insights to benefit the life sciences market. The […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the launch of its TruGenome Undiagnosed Disease Test provided by the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory (ICSL). This new service uses whole human genome sequencing to assist physicians in identifying the underlying genetic cause of a rare or undiagnosed disease. By providing physicians with more comprehensive […]
SAN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Center for Molecular Medicine, doing business as Sequenom Laboratories, has launched the Enhanced Sequencing Series for its MaterniT21™ PLUS laboratory-developed test (LDT). The MaterniT21 PLUS test will begin reporting additional […]
GERMANTOWN, Maryland, and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with Clovis Oncology (NASDAQ: CLVS) to co-develop and co-commercialize a companion diagnostic test to guide the use of CO-1686, a novel Clovis Oncology product candidate currently in clinical development. The Clovis drug candidate will initially target an […]
SAN DIEGO, CA –– Genalyte, Inc., today announced that it has received a $1 million SBIR grant from the National Cancer Institute (NCI) to develop a biomarker panel to profile tumor antigen-associated (TAA) autoantibodies. The panel will run on Genalyte’s multiplexed MaverickTM Detection System, which provides rapid, accurate, robust and scalable detection of proteins and […]
Lausanne (Switzerland), Mechelen (Belgium) and Barcelona (Spain) — Today Biocartis and Hospital del Mar announced their licence agreement on the EGFR biomarker for colon cancer. This agreement enables Biocartis to develop a new colon cancer test, whereby a specific EGFR mutation can be rapidly and accurately detected in patients, which will enable doctors to recommend […]
Vancouver, BC and Seattle, WA – The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics Inc. will use their biomarker expertise in collaboration with the Jain Foundation, Inc. to identify blood-based biomarkers of disease in individuals with a rare form of muscular dystrophy, called Limb?girdle muscular dystrophy 2B (LGMD2B) […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
